HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

Published online before print October 4, 2005

This Article Full Text Full Text (PDF) All Versions of this Article: jlb.0405216v1 78/6/1192    most recent Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Cabral, G. A. Articles by Marciano-Cabral, F. Search for Related Content PubMed PubMed Citation Articles by Cabral, G. A. Articles by Marciano-Cabral, F.

(Journal of Leukocyte Biology. 2005;78:1192-1197.)
© 2005 by Society for Leukocyte Biology

Cannabinoid receptors in microglia of the central nervous system: immune functional relevance

Department of Microbiology and Immunology, Virginia Commonwealth University, School of Medicine, Richmond, Virginia

¹ Correspondence: Department of Microbiology and Immunology, Virginia Commonwealth University, School of Medicine, 1101 E. Marshall Street, Richmond, VA 23298-0678. E-mail: gacabral{at}hsc.vcu.edu

ABSTRACT

Microglia, resident macrophages of the brain, function as immune effector and accessory cells. Paradoxically, they not only play a role in host defense and tissue repair but also have been implicated in a variety of neuropathological processes. Microglia, in addition to exhibiting phenotypic markers for macrophages, express CB₁ and CB₂ cannabinoid receptors. Recent studies suggest the existence of a third, yet-to-be cloned, non-CB₁, non-CB₂ cannabinoid receptor. These receptors appear to be functionally relevant within defined windows of microglial activation state and have been implicated as linked to cannabinoid modulation of chemokine and cytokine expression. The recognition that microglia express cannabinoid receptors and that their activation results in modulation of select cellular activities suggests that they may be amenable to therapeutic manipulation for ablating untoward inflammatory responses in the central nervous system.

Key Words: brain immune modulation • cytokines • marijuana • nitric oxide

This article has been cited by other articles:

				J. Zhang and C. Chen Endocannabinoid 2-Arachidonoylglycerol Protects Neurons by Limiting COX-2 Elevation J. Biol. Chem., August 15, 2008; 283(33): 22601 - 22611. [Abstract] [Full Text] [PDF]

				R. Russo, J. LoVerme, G. La Rana, T. R. Compton, J. Parrott, A. Duranti, A. Tontini, M. Mor, G. Tarzia, A. Calignano, et al. The Fatty Acid Amide Hydrolase Inhibitor URB597 (Cyclohexylcarbamic Acid 3'-Carbamoylbiphenyl-3-yl Ester) Reduces Neuropathic Pain after Oral Administration in Mice J. Pharmacol. Exp. Ther., July 1, 2007; 322(1): 236 - 242. [Abstract] [Full Text] [PDF]

				K. Benamar, M. Yondorf, J. J. Meissler, E. B. Geller, R. J. Tallarida, T. K. Eisenstein, and M. W. Adler A Novel Role of Cannabinoids: Implication in the Fever Induced by Bacterial Lipopolysaccharide J. Pharmacol. Exp. Ther., March 1, 2007; 320(3): 1127 - 1133. [Abstract] [Full Text] [PDF]

				C. Borner, V. Hollt, W. Sebald, and J. Kraus Transcriptional regulation of the cannabinoid receptor type 1 gene in T cells by cannabinoids J. Leukoc. Biol., January 1, 2007; 81(1): 336 - 343. [Abstract] [Full Text] [PDF]